Disruption of the neurexin 1 gene is associated with schizophrenia

  • Dan Rujescu
    Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Andres Ingason
    deCODE genetics, Reykjavík, Iceland
  • Sven Cichon
    Department of Genomics, Life and Brain Center
  • Olli P.H. Pietiläinen
    Department for Molecular Medicine, National Public Health Institute, Helsinki, Finland
  • Michael R. Barnes
    Computational Biology, GlaxoSmithKline Pharmaceuticals, Harlow, Essex, UK
  • Timothea Toulopoulou
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Marco Picchioni
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Evangelos Vassos
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Ulrich Ettinger
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Elvira Bramon
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Robin Murray
    Division of Psychological Medicine, Institute of Psychiatry, King's College, London, UK
  • Mirella Ruggeri
    Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
  • Sarah Tosato
    Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
  • Chiara Bonetto
    Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
  • Stacy Steinberg
    deCODE genetics, Reykjavík, Iceland
  • Engilbert Sigurdsson
    Department of Psychiatry, National University Hospital, Reykjavík, Iceland
  • Thordur Sigmundsson
    Department of Psychiatry, National University Hospital, Reykjavík, Iceland
  • Hannes Petursson
    Department of Psychiatry, National University Hospital, Reykjavík, Iceland
  • Arnaldur Gylfason
    deCODE genetics, Reykjavík, Iceland
  • Pall I. Olason
    deCODE genetics, Reykjavík, Iceland
  • Gudmundur Hardarsson
    deCODE genetics, Reykjavík, Iceland
  • Gudrun A. Jonsdottir
    deCODE genetics, Reykjavík, Iceland
  • Omar Gustafsson
    deCODE genetics, Reykjavík, Iceland
  • Ragnheidur Fossdal
    deCODE genetics, Reykjavík, Iceland
  • Ina Giegling
    Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Hans-Jürgen Möller
    Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Annette M. Hartmann
    Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Per Hoffmann
    Department of Genomics, Life and Brain Center
  • Caroline Crombie
    Department of Mental Health, University of Aberdeen, Aberdeen, Scotland
  • Gillian Fraser
    Department of Mental Health, University of Aberdeen, Aberdeen, Scotland
  • Nicholas Walker
    Ravenscraig Hospital, Greenock, Scotland
  • Jouko Lonnqvist
    Department of Mental Health and Addiction, National Public Health Institute, Helsinki, Finland
  • Jaana Suvisaari
    Department of Mental Health and Addiction, National Public Health Institute, Helsinki, Finland
  • Annamari Tuulio-Henriksson
    Department of Mental Health and Addiction, National Public Health Institute, Helsinki, Finland
  • Srdjan Djurovic
    Institute of Psychiatry, University of Oslo, Oslo, Norway
  • Ingrid Melle
    Institute of Psychiatry, University of Oslo, Oslo, Norway
  • Ole A. Andreassen
    Institute of Psychiatry, University of Oslo, Oslo, Norway
  • Thomas Hansen
    Research Institute of Biological Psychiatry Mental Health Centre Sct. Hans, Copenhagen University Hospital, Roskilde, Denmark
  • Thomas Werge
    Research Institute of Biological Psychiatry Mental Health Centre Sct. Hans, Copenhagen University Hospital, Roskilde, Denmark
  • Lambertus A. Kiemeney
    Department of Epidemiology and Biostatistics (133 EPIB)
  • Barbara Franke
    Department of Human Genetics, Radboud University Nijmejen Medical Centre, Nijmegen, The Netherlands
  • Joris Veltman
    Department of Human Genetics, Radboud University Nijmejen Medical Centre, Nijmegen, The Netherlands
  • Jacobine E. Buizer-Voskamp
    Rudolf Magnus Institute of Neuroscience, Department of Psychiatry
  • Chiara Sabatti
    Departments of Human Genetics and Statistics, UCLA, Los Angeles, CA
  • Roel A. Ophoff
    Complex Genetics Section, DBG-Department of Medical Genetics and Rudolf Magnus Institute
  • Marcella Rietschel
    Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health Mannheim, University of Heidelberg, Mannheim, Germany
  • Markus M. Nöthen
    Department of Genomics, Life and Brain Center
  • Kari Stefansson
    Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Leena Peltonen
    Department for Molecular Medicine, National Public Health Institute, Helsinki, Finland
  • David St Clair
    Department of Mental Health, University of Aberdeen, Aberdeen, Scotland
  • Hreinn Stefansson
    deCODE genetics, Reykjavík, Iceland
  • David A. Collier
    MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London, UK

書誌事項

公開日
2008-10-22
DOI
  • 10.1093/hmg/ddn351
公開者
Oxford University Press (OUP)

この論文をさがす

収録刊行物

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ